Tumor-seeking bacterial missiles

dc.contributor.authorCavic, Georgeen
dc.contributor.authorFahrer, Audeen
dc.date.accessioned2025-06-30T17:38:13Z
dc.date.available2025-06-30T17:38:13Z
dc.date.issued2025-01-05en
dc.description.abstractIn this Research Highlight, we discuss an exceptionally elegant and far-reaching study from the Arpaia lab at Columbia University, who have engineered a probiotic Escherichia coli strain to eliminate cancer.en
dc.description.statusPeer-revieweden
dc.format.extent4en
dc.identifier.issn0818-9641en
dc.identifier.scopus85216472293en
dc.identifier.urihttps://hdl.handle.net/1885/733765914
dc.language.isoenen
dc.rights© 2025 The Author(s)en
dc.sourceImmunology and Cell Biologyen
dc.titleTumor-seeking bacterial missilesen
dc.typeCommentaryen
dspace.entity.typePublicationen
local.bibliographicCitation.lastpage4en
local.bibliographicCitation.startpage1en
local.contributor.affiliationCavic, George; Division of Biomedical Science & Biochemistry, Research School of Biology, ANU College of Science and Medicine, The Australian National Universityen
local.contributor.affiliationFahrer, Aude; Division of Biomedical Science & Biochemistry, Research School of Biology, ANU College of Science and Medicine, The Australian National Universityen
local.identifier.citationvolume103en
local.identifier.doi10.1111/imcb.12844en
local.identifier.pure8a22f4fd-cb9f-4964-b83a-d6120c220534en
local.identifier.urlhttps://www.scopus.com/pages/publications/85216472293en
local.type.statusPublisheden

Downloads